University of Pennsylvania School of Medicine researchers have found that a common anti-diabetic drug might enhance the effectiveness of vaccines. The findings are described this week in an advanced online publication of Nature. In the photo, two co-authors of the study, Erika Pearce, PhD and Gretchen Harms, view T-cells on a computer screen.
Credit: University of Pennsylvania School of Medicine
Download full-size version |